Prevalence and determinants of smoke-free homes in 12 European countries: the TackSHS Survey
Year: 2024
Type: article
Study design: Observational Study
Abstract: Background Homes are one of the primary locations where people are exposed to second-hand smoke (SHS) in Europe. We describe the prevalence and identify the main determinants of having home-smoking restrictions in 12 European countries. Methods Cross-sectional survey in 12 European countries conducted in 2017–2018 (TackSHS project). Approximately 1000 participants representing the general population aged ≥15 years of each country were interviewed face to face. Individual- and country-level characteristics were explored through adjusted prevalence ratios (PRs) obtained from multilevel Poisson models with random effects. Results Among 11 734 participants, 70.2% (95% confidence interval (CI) 69.4–71.0%) had smoke-free homes and 17.5% (95% CI 16.8–18.2%) had partial home-smoking restrictions in place. Prevalence of smoke-free homes ranged from 44.4% in Greece to 84.5% in England. Having a smoke-free home was significantly inversely associated with current (PR=0.60) or former (PR=0.95) smoking and living in a household with one (PR=0.70) or two or more (PR=0.58) people who smoke. It was also significantly associated with being ≥65 years old (PR=1.05), being female (PR=1.07), having a high educational level (PR=1.09) and living with children (PR=1.09). Having a smoke-free home was associated with living in northern Europe, while partial home-smoking restrictions were more likely among respondents from eastern Europe and countries with lowerper capitagross domestic product. Conclusions The prevalence of smoke-free homes in Europe is relatively high, but with large variability across countries. European countries with a lower prevalence of smoke-free homes should implement tailored interventions targeting identified determinants and incorporate the success of other countries.
Source: ERJ Open Research
Institutions: Instituto de Salud Carlos III, Institut d'Investigació Biomédica de Bellvitge, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Institut Català d'Oncologia, Centro de Investigación Biomédica en Red, Universitat de Barcelona, Mario Negri Institute for Pharmacological Research, University of California, San Francisco, Philip R. Lee Institute for Health Policy Studies, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, University of Stirling, Agència de Salut Pública de Catalunya, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Agencia de Salud Pública de Barcelona, Generalitat de Catalunya, Departament de Salut
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $808
OpenAlex ID: W4404753408
